ArticleJournal of thoracic disease2019
Robot-assisted esophagogastric reconstruction in minimally invasive Ivor Lewis esophagectomy.
Article in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
- Technical details for a robot-assisted hand-sewn esophago-gastric anastomosis during minimally invasive Ivor Lewis esophagectomy.Surgical endoscopy · 2022Article
- Double-Docking Technique, an Optimized Process for Intrathoracic Esophagogastrostomy in Robot-Assisted Ivor Lewis Esophagectomy.Frontiers in surgery · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough the incidence of esophagogastric junction cancer has increased considerably in recent years, the application of minimally invasive Ivor Lewis esophagectomy, especially in East Asia, is still much rarer than the McKeown approach. The reconstruction of the alimentary tract is one of the main technical challenges under traditional endoscopy. The robotic surgical system with high-resolution 3D images and multiarticulate instruments may help simplify this procedure. Here, we describe our experience in the gastric tube and esophagogastric anastomosis construction, and the initial clinical results for Ivor Lewis robot-assisted minimally invasive esophagectomy (RAMIE).
methodsA retrospective study of all patients undergoing Ivor Lewis RAMIE with circular stapled anastomosis at a single institution from December 2016 to June 2018 was performed. Operative and postoperative outcomes were recorded.
resultsTwenty-four patients [median age, 63 years (range, 49-77 years)] underwent Ivor Lewis RAMIE during the study period with a four-arm robotic platform. Four patients (16.7%) received neoadjuvant therapy. The median estimated blood loss was 120 mL (range, 50-210 mL). The median operating time was 352.5 min (range, 259-485 min). There was no conversion to an open surgical procedure. Postoperative complications occurred in 3 (12.5%) patients. Complications included pneumonia in two patients (8.3%) and mediastinitis in 1 (4.2%). The median stay in the intensive care unit was 1 d (range, 0-8 d) and the median postoperative hospital stay was 11 d (range, 8-30 d). All patients had an R0 resection. The median number of nodes removed was 19 (range, 11-30) and the median number of positive nodes removed was 1 (range, 0-8).
conclusionsOur initial results indicate that Ivor Lewis RAMIE may be a safe and feasible alternative to open and endoscopic Ivor Lewis esophagectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.